TrialPain research & management2017

Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Trial.

Neil A Hagen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.